APPLICATION
ANDA076156
TYPE
ANDA
ORIGINAL APPROVAL
2003-04-18
LATEST ACTION
2015-11-18
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Prescription
Products
IPRATROPIUM BROMIDEPrescription
IPRATROPIUM BROMIDE 0.021MG/SPRAY · SPRAY, METERED · NASAL
Approval history
2015-11-18Labeling · Supplement 20 · standardAP
2009-03-03Labeling · Supplement 13AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.